Xvivo Perfusion AB (publ)
XVIPY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $416 | $546 | $247 | $399 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $117 | $98 | $100 | $60 |
| Inventory | $227 | $142 | $107 | $78 |
| Other Curr. Assets | $53 | $41 | $20 | $12 |
| Total Curr. Assets | $813 | $826 | $468 | $548 |
| Property Plant & Equip (Net) | $149 | $98 | $48 | $26 |
| Goodwill | $682 | $591 | $625 | $460 |
| Intangibles | $49 | $629 | $553 | $465 |
| Long-Term Investments | $1 | $1 | $0 | $1 |
| Tax Assets | $0 | $51 | $39 | $42 |
| Other NC Assets | $709 | $0 | $0 | $0 |
| Total NC Assets | $1,590 | $1,369 | $1,266 | $995 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,403 | $2,196 | $1,733 | $1,543 |
| Liabilities | – | – | – | – |
| Payables | $39 | $36 | $38 | $21 |
| Short-Term Debt | $11 | $10 | $6 | $14 |
| Tax Payable | $0 | $12 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $3 | $47 |
| Other Curr. Liab. | $127 | $76 | $86 | $76 |
| Total Curr. Liab. | $178 | $134 | $135 | $105 |
| LT Debt | $23 | $21 | $4 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $0 | $29 | $26 | $25 |
| Other NC Liab. | $45 | $66 | $138 | $125 |
| Total NC Liab. | $68 | $116 | $168 | $153 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $34 | $31 | $10 | $6 |
| Total Liabilities | $246 | $251 | $303 | $257 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $292 | $120 | $28 | $9 |
| AOCI | $92 | $0 | $88 | $22 |
| Other Equity | $1,772 | $1,825 | $1,314 | $1,253 |
| Total Equity | $2,157 | $1,945 | $1,430 | $1,285 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,403 | $2,196 | $1,733 | $1,543 |
| Net Debt | -$381 | -$514 | -$237 | -$383 |